CN106011204B - Method for synthesizing echinocandin B by fermentation method - Google Patents
Method for synthesizing echinocandin B by fermentation method Download PDFInfo
- Publication number
- CN106011204B CN106011204B CN201610544096.7A CN201610544096A CN106011204B CN 106011204 B CN106011204 B CN 106011204B CN 201610544096 A CN201610544096 A CN 201610544096A CN 106011204 B CN106011204 B CN 106011204B
- Authority
- CN
- China
- Prior art keywords
- fermentation
- culture
- medium
- stage
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 168
- 230000004151 fermentation Effects 0.000 title claims abstract description 168
- 108010062092 echinocandin B Proteins 0.000 title claims abstract description 88
- FAUOJMHVEYMQQG-HVYQDZECSA-N echinocandin B Chemical compound C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCC\C=C/C\C=C/CCCCC)[C@@H](C)O)=CC=C(O)C=C1 FAUOJMHVEYMQQG-HVYQDZECSA-N 0.000 title claims abstract description 88
- 238000000034 method Methods 0.000 title claims abstract description 25
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 7
- 241000351920 Aspergillus nidulans Species 0.000 claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 57
- 229930195725 Mannitol Natural products 0.000 claims description 57
- 239000000594 mannitol Substances 0.000 claims description 57
- 235000010355 mannitol Nutrition 0.000 claims description 57
- 239000002609 medium Substances 0.000 claims description 33
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 17
- 238000011218 seed culture Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 10
- 239000001963 growth medium Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 5
- 229960002429 proline Drugs 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 4
- 229930182821 L-proline Natural products 0.000 claims description 4
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 4
- 235000019483 Peanut oil Nutrition 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 229960003104 ornithine Drugs 0.000 claims description 4
- 239000000312 peanut oil Substances 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 235000012343 cottonseed oil Nutrition 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims 2
- 108010064760 Anidulafungin Proteins 0.000 abstract description 10
- 229960003348 anidulafungin Drugs 0.000 abstract description 10
- JHVAMHSQVVQIOT-MFAJLEFUSA-N anidulafungin Chemical compound C1=CC(OCCCCC)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=O)N[C@@H]2C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C2)[C@@H](C)O)[C@H](O)[C@@H](O)C=2C=CC(O)=CC=2)[C@@H](C)O)=O)C=C1 JHVAMHSQVVQIOT-MFAJLEFUSA-N 0.000 abstract description 10
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 239000002243 precursor Substances 0.000 abstract description 7
- 238000012258 culturing Methods 0.000 abstract description 4
- 230000035611 feeding Effects 0.000 description 31
- 230000000694 effects Effects 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 17
- 238000003786 synthesis reaction Methods 0.000 description 16
- 239000000047 product Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000002028 Biomass Substances 0.000 description 5
- 208000031888 Mycoses Diseases 0.000 description 4
- 230000000843 anti-fungal effect Effects 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000011217 control strategy Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 206010017533 Fungal infection Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229930000044 secondary metabolite Natural products 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010049047 Echinocandins Proteins 0.000 description 2
- 206010042938 Systemic candida Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 201000003984 candidiasis Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- COHFSKKGVFGDFH-YUPRTTJUSA-N (2s,3s,4s)-3-hydroxy-4-methylpyrrolidine-2-carboxylic acid Chemical compound C[C@H]1CN[C@H](C(O)=O)[C@H]1O COHFSKKGVFGDFH-YUPRTTJUSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- -1 4-carbonyl-L-proline Chemical compound 0.000 description 1
- 206010060921 Abdominal abscess Diseases 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010020326 Caspofungin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 108010021062 Micafungin Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 206010030154 Oesophageal candidiasis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000017773 candidemia Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- JYIKNQVWKBUSNH-WVDDFWQHSA-N caspofungin Chemical compound C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3CC[C@H](O)[C@H]3C(=O)N[C@H](NCCN)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@H](O)CCN)=CC=C(O)C=C1 JYIKNQVWKBUSNH-WVDDFWQHSA-N 0.000 description 1
- 229960003034 caspofungin Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960002159 micafungin Drugs 0.000 description 1
- PIEUQSKUWLMALL-YABMTYFHSA-N micafungin Chemical compound C1=CC(OCCCCC)=CC=C1C1=CC(C=2C=CC(=CC=2)C(=O)N[C@@H]2C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C2)[C@H](O)CC(N)=O)[C@H](O)[C@@H](O)C=2C=C(OS(O)(=O)=O)C(O)=CC=2)[C@@H](C)O)=O)=NO1 PIEUQSKUWLMALL-YABMTYFHSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
(一)技术领域(1) Technical field
本发明涉及一种棘白菌素B的制备方法,特别涉及一种分阶段控制环境因素(温度)与补料的方法发酵生产阿尼芬净前体化合物棘白菌素B(ECB)的方法。The present invention relates to a preparation method of echinocandin B, in particular to a method for fermenting and producing anidungin precursor compound echinocandin B (ECB) by controlling environmental factors (temperature) and feeding in stages .
(二)背景技术(2) Background technology
近年来,器官移植手术导致免疫抑制剂的大量使用,化疗和更具有侵袭性的医疗方法的应用等多种原因造成免疫低下患者增多,真菌感染发病率显著升高,尤其是深部真菌感染的发病率和病死率逐年增加。据世界卫生组织(WHO)2004年的统计估计,全球每年的系统性真菌感染人数为33.5万。其中最常见的是系统性念珠菌病,约占所有此类感染的70%左右,而其引起的死亡率又高达40%左右。随着医学的不断进步,20世纪90年代后,各种抗真菌药物不断问世,为治疗各类真菌疾病带来革命性的进步。由于对抗真菌药物的需求逐年攀升,使得其市场规模越加旺盛。In recent years, organ transplantation has led to the extensive use of immunosuppressants, chemotherapy and the application of more invasive medical methods, etc., resulting in an increase in the number of immunocompromised patients, and a significant increase in the incidence of fungal infections, especially deep fungal infections. The rate and case fatality rate are increasing year by year. According to the statistics of the World Health Organization (WHO) in 2004, the global annual number of systemic fungal infections is 335,000. The most common of these is systemic candidiasis, which accounts for around 70% of all such infections, and causes mortality rates as high as around 40%. With the continuous progress of medicine, after the 1990s, various antifungal drugs have been continuously developed, bringing revolutionary progress to the treatment of various fungal diseases. Due to the increasing demand for antifungal drugs year by year, its market size has become more and more prosperous.
棘白菌素(Echinocandin)类抗生素是20世纪70年代发现的一组天然产物,具有类似的环状多肽核心和不同的脂肪酸侧链的结构特征,能够非竞争性地抑制真菌细胞壁β-1,3-葡聚糖合成酶的活性,从而达到抗真菌的目的。其中阿尼芬净(Anidulafungin)是继卡泊芬净(Caspofungin)、米卡芬净(Micafungin)之后的第三代全身抗真菌类棘白菌素衍生物药物,2006年2月21日,由辉瑞公司生产的阿尼芬净通过了美国FDA认证,主要治疗念珠菌血症和其他形式的念珠菌感染(腹腔脓肿、腹膜炎)和食管念珠菌等。阿尼芬净是由前体化合物棘白菌素B(ECB)经犹他游动放线菌产生的酰化酶作用脱去侧链亚油酰基,然后在DMF中与活性中间体4"-戊氧基-[1,1',4',1"]三苯基-4-甲酸-2,4,5-三氯-苯基酯反应制得。Echinocandin antibiotics are a group of natural products discovered in the 1970s. They have similar structural features of a cyclic polypeptide core and different fatty acid side chains, and can non-competitively inhibit fungal cell wall β-1, 3-glucan synthase activity, so as to achieve the purpose of antifungal. Anidulafungin is the third generation of systemic antifungal echinocandin derivatives after Caspofungin and Micafungin. On February 21, 2006, by Anidulafungin produced by Pfizer has passed the US FDA certification, mainly for the treatment of candidemia and other forms of Candida infections (abdominal abscess, peritonitis) and esophageal candida. Anidungin is a precursor compound echinocandin B (ECB) that removes the side chain linoleyl group by the action of acylase produced by Actinomyces utah, and then reacts with the
根据文献和专利报道,目前国内外ECB均是利用微生物发酵法进行制备,其中主要为构巢曲霉(Aspergillus nidulans)的发酵。Maria Papagianni等人综述了发酵过程中的接种量、碳氮源种类及浓度、pH、温度及搅拌速率等因素对构巢曲霉生长的影响。ECB是合成阿尼芬净的主要前体化合物,其发酵单位的高低将直接影响阿尼芬净的市场前景。FritzBenz等学者通过红外、核磁共振等方法确定了ECB的分子结构,且发现其水解成分中包括了亚油酸、4-羟基-L-脯氨酸、4-羰基-L-脯氨酸、L-苏氨酸、(2S,3S,4S)-4-甲基-3-羟脯氨酸等,并且发酵培养基中添加碳酸盐、磷酸盐、硫酸盐及硝酸盐等组分对ECB产量的提高均有促进作用。According to literature and patent reports, ECB is currently prepared by microbial fermentation at home and abroad, and the main one is the fermentation of Aspergillus nidulans. Maria Papagianni et al. reviewed the effects of inoculum size, types and concentrations of carbon and nitrogen sources, pH, temperature and stirring rate on the growth of Aspergillus nidulans during the fermentation process. ECB is the main precursor compound for the synthesis of anidulafungin, and the level of its fermentation unit will directly affect the market prospect of anidulafungin. Scholars such as FritzBenz determined the molecular structure of ECB by infrared, nuclear magnetic resonance and other methods, and found that its hydrolyzed components included linoleic acid, 4-hydroxy-L-proline, 4-carbonyl-L-proline, L - Threonine, (2S,3S,4S)-4-methyl-3-hydroxyproline, etc., and the addition of carbonate, phosphate, sulfate and nitrate to the fermentation medium has an effect on ECB production increase has a stimulative effect.
次级代谢产物发酵过程分为两个阶段:细胞生长阶段和产品合成阶段,一般来说,两个阶段的最适温度不同。温度两阶段控制策略是一种容易操作且有效的发酵策略,可以满足菌体在不同阶段的温度要求。补料策略能避免发酵过程中的底物抑制,保证发酵过称在合适的底物浓度下进行。在次级代谢产物发酵中,温度两阶段控制策略和补料策略有重要意义。美国礼来公司自从上世纪80年代以来,进行多年的棘白菌素B发酵工艺条件优化工作,但发酵产量一直没有较大突破。目前主要问题是国内ECB的发酵制备水平仍然较低,因此利用发酵代谢调控手段对发酵过程进行优化,提高ECB产量,对于阿尼芬净的工业化生产来说具有极其重要的意义。The secondary metabolite fermentation process is divided into two stages: the cell growth stage and the product synthesis stage. Generally speaking, the optimum temperature of the two stages is different. The two-stage temperature control strategy is an easy-to-operate and effective fermentation strategy, which can meet the temperature requirements of bacteria in different stages. The feeding strategy can avoid substrate inhibition during the fermentation process and ensure that the fermentation process is carried out at an appropriate substrate concentration. In secondary metabolite fermentation, two-stage temperature control strategy and feeding strategy are of great significance. Since the 1980s, Eli Lilly and Company in the United States has been optimizing the fermentation conditions of echinocandin B for many years, but there has been no major breakthrough in fermentation yield. At present, the main problem is that the level of domestic ECB fermentation preparation is still low. Therefore, it is extremely important for the industrial production of anidulafungin to optimize the fermentation process by means of fermentation metabolism regulation and increase the production of ECB.
(三)发明内容(3) Contents of the invention
本发明目的在于针对现有的ECB发酵产量低的缺陷,提供一种提高ECB发酵水平的技术。The purpose of the present invention is to provide a technology for improving the fermentation level of ECB in view of the defect that the existing ECB fermentation yield is low.
本发明采用的技术方案是:The technical scheme adopted in the present invention is:
本发明提供一种发酵法合成棘白菌素B的方法,所述方法为:以构巢曲霉为生产菌株,接种至发酵培养基中,分两个阶段进行培养,第一阶段在30~37℃培养4~8天,随后第二阶段在23~27℃培养4~8天,将发酵液分离纯化,获得棘白菌素B(ECB);所述发酵培养基终浓度组成为:甘油5~50g/L,蛋白胨5~50g/L,L-脯氨酸1~5g/L,甘露醇10~100g/L,黄豆饼粉10~100g/L,鸟氨酸1~5g/L,花生油5~50g/L,K2HPO4·3H2O 2~20g/L,溶剂为蒸馏水,pH值自然,优选发酵培养基终浓度组成为:甘油1%,蛋白胨0.9%,L-脯氨酸0.5%,甘露醇9.7%,黄豆饼粉4%,L-鸟氨酸0.5%,花生油2%,K2HPO4·3H2O 0.84%,溶剂为蒸馏水,pH值6.8~7.0。本发明中培养基组成以质量体积(w/v)百分比表示,某组分浓度1%即表示100mL培养基中含有该组分1g。The present invention provides a method for synthesizing echinocandin B by fermentation. Cultivated at ℃ for 4-8 days, and then cultured at 23-27 ℃ for 4-8 days in the second stage, and separated and purified the fermentation broth to obtain echinocandin B (ECB); the final concentration of the fermentation medium was composed of: glycerol 5 ~50g/L, peptone 5~50g/L, L-proline 1~5g/L,
进一步,所述构巢曲霉为构巢曲霉(Aspergillus nidulans)ZJB09223,保藏于中国典型培养物保藏中心,地址:中国,武汉,武汉大学,邮编430072,保藏编号为CCTCC NO:M2012300,保藏日期为2012年07月25日,已在《Mutagenesis breeding of highechinocandin B producing strain and further titer improvement with culturemedium optimization》中公开。Further, the Aspergillus nidulans is Aspergillus nidulans ZJB09223, which is preserved in the China Center for Type Culture Collection, address: Wuhan University, Wuhan, China, zip code 430072, preservation number is CCTCC NO: M2012300, preservation date is 2012 On July 25th, it was published in "Mutagenesis breeding of highechinocandin B producing strain and further titer improvement with culturemedium optimization".
进一步,所述第一阶段培养6天转至第二阶段培养。Further, the first-stage culture for 6 days was transferred to the second-stage culture.
进一步,所述第一阶段在30℃培养6天,然后在第7天转换至第二阶段,在25℃培养6天。Further, the first stage was cultured at 30°C for 6 days, and then switched to the second stage at 25°C for 6 days on the 7th day.
进一步,同时在第一阶段和第二阶段发酵培养过程中向培养液中补加甘露醇,甘露醇总添加量为30~50g/L培养液,优选所述甘露醇添加方法为:在第一阶段和第二阶段发酵的第3~9天,补加1~3次甘露醇,更优选分别在发酵培养的第3天、第6天和第9天,向培养液中添加1次甘露醇,每次添加量为15g/L培养液。Further, mannitol is added to the culture solution during the first and second stages of fermentation and culture at the same time, and the total amount of mannitol added is 30-50 g/L of the culture solution. Preferably, the method for adding mannitol is: in the first stage. On the 3rd to 9th days of the first and second stage fermentation, mannitol is added 1 to 3 times, more preferably on the 3rd, 6th and 9th days of the fermentation culture, respectively, add mannitol to the culture medium once , the amount of each addition is 15g/L culture medium.
进一步,所述构巢曲霉在发酵培养前先进行斜面培养和种子培养:(1)斜面培养:将构巢曲霉接种至斜面培养基,在25℃培养12天,获得斜面菌体;所述斜面培养基终浓度为:土豆200g/L,蔗糖20g/L,琼脂粉20g/L,溶剂为水,pH值自然;(2)种子培养:将步骤(1)斜面菌体接种至种子培养基,25~30℃培养24~48h,获得种子液;种子培养基终浓度组成为:棉籽粉25g/L,葡萄糖10g/L,甘油10g/L,pH6.8~7.0,溶剂为水。Further, the Aspergillus nidulans is subjected to slant culture and seed culture before fermentation culture: (1) slant culture: inoculate Aspergillus nidulans into a slant medium, and culture at 25°C for 12 days to obtain slant cells; the slant The final concentration of the medium is: potato 200g/L, sucrose 20g/L, agar powder 20g/L, the solvent is water, and the pH value is natural; (2) seed culture: inoculate step (1) slant cells into the seed medium, Incubate at 25-30°C for 24-48h to obtain seed liquid; the final concentration of seed medium is composed of cottonseed meal 25g/L, glucose 10g/L, glycerol 10g/L, pH 6.8-7.0, and water as solvent.
进一步,本发明所述发酵法合成棘白菌素B的方法为:将构巢曲霉CCTCC NO:M2012300接种至发酵培养基中,分两个阶段进行培养,第一阶段在30℃培养6天,然后第二阶段在25℃培养6天,同时在第一阶段和第二阶段发酵培养过程的第3天、第6天和第9天分别向培养液中补加甘露醇,每次添加量为15g/L培养液,将发酵液分离纯化,获得棘白菌素B。Further, the method for synthesizing echinocandin B by the fermentation method of the present invention is as follows: inoculating Aspergillus nidulans CCTCC NO: M2012300 into the fermentation medium, and culturing in two stages, the first stage is cultured at 30°C for 6 days, Then the second stage was cultured at 25°C for 6 days, and mannitol was added to the culture solution on the 3rd, 6th and 9th days of the first and second stages of fermentation and culture, respectively, and the amount of each addition was 15g/L culture broth, the fermentation broth was separated and purified to obtain echinocandin B.
本发明旨在通过温度两阶段与补料相协同以实现ECB产量的提高,从而为工业化生产ECB提供技术支持,为生产阿尼芬净奠定基础。The invention aims to realize the increase of ECB output through the synergy of temperature two-stage and feeding, so as to provide technical support for industrialized production of ECB, and to lay a foundation for the production of anidulafungin.
与现有技术相比,本发明的有益效果主要体现在:本发明提供一种通过温度两阶段或与补料相协同提高阿尼芬净前体化合物棘白菌素B产量的方法,通过温度两阶段与补料相协同提高阿尼芬净前体化合物ECB产量。结果表明,在发酵培养体系中最高产量达到2.05g/L,约为原始的传统培养方案的1.7倍,比单独两阶段提高了10%。本发明对于利用构巢曲霉(Aspergillus nidulans)为生产菌株发酵生产ECB具有重要意义。Compared with the prior art, the beneficial effects of the present invention are mainly reflected in: the present invention provides a method for increasing the yield of anidulafungin precursor compound echinocandin B by two-stage temperature or synergistically with feeding. Two-stage synergy with feeding increases the production of anidulafungin precursor compound ECB. The results showed that the highest yield in the fermentation culture system reached 2.05 g/L, which was about 1.7 times that of the original traditional culture scheme, and was 10% higher than that of the two-stage alone. The invention has important significance for using Aspergillus nidulans as a production strain to ferment and produce ECB.
(四)附图说明(4) Description of drawings
图1不同培养温度对菌体干重的影响;Figure 1 The effect of different culture temperatures on the dry weight of bacteria;
图2不同培养温度对ECB产量的影响;Fig. 2 The effect of different culture temperature on ECB yield;
图3第3天变温对ECB发酵的影响;Fig. 3 The effect of temperature change on ECB fermentation on
图4第9天变温对ECB发酵的影响;Fig. 4 The effect of temperature change on ECB fermentation on the 9th day;
图5第6天变温对ECB发酵的影响;Figure 5 The effect of temperature change on ECB fermentation on the 6th day;
图6不同补料浓度对ECB发酵的影响;Fig. 6 Effects of different feed concentrations on ECB fermentation;
图7第3天补料对ECB发酵的影响;Figure 7 Effect of feeding on ECB fermentation on
图8第6天补料对ECB发酵的影响;Figure 8 Effect of feeding on ECB fermentation on
图9第9天补料对ECB发酵的影响;Fig. 9 The effect of feeding on ECB fermentation on
图10第3、6、9天补料对ECB发酵的影响;Figure 10 Effects of feeding on ECB fermentation on
图11温度两阶段控制策略与补料策略相互协同对ECB发酵的影响。Fig. 11 The effect of synergistic effect of two-stage temperature control strategy and feeding strategy on ECB fermentation.
(五)具体实施方式(5) Specific implementation methods
下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此:The present invention is further described below in conjunction with specific embodiment, but the protection scope of the present invention is not limited to this:
实施例1温度对构巢曲霉ZJB09223生长和ECB合成所产生的影响Example 1 The effect of temperature on the growth of Aspergillus nidulans ZJB09223 and synthesis of ECB
(1)将构巢曲霉ZJB09223接种至斜面培养基,在25℃培养12天,获得斜面菌体;所述斜面培养基终浓度为:土豆200g/L(取水煮上清),蔗糖20g/L,琼脂粉20g/L,溶剂为水,pH值自然,经121℃,20min高温灭菌冷却后使用。(1) Inoculate Aspergillus nidulans ZJB09223 into slant medium, cultivate at 25° C. for 12 days to obtain slant cells; the final concentration of the slant medium is: potato 200g/L (boil supernatant), sucrose 20g/L , Agar powder 20g/L, solvent is water, pH value is natural, after 121 ℃, 20min high temperature sterilization and cooling before use.
(2)将步骤(1)斜面菌体接种至种子培养基,25℃培养48h,获得种子液;种子培养基终浓度组成为:棉籽粉25g/L,葡萄糖10g/L,甘油10g/L,pH6.8~7.0,溶剂为水,经115℃,30min高温灭菌冷却后使用。(2) Inoculate the slanted cells in step (1) into the seed medium, and cultivate at 25°C for 48 hours to obtain seed liquid; the final concentration of the seed medium is composed of: cottonseed meal 25g/L, glucose 10g/L, glycerol 10g/L, pH6.8~7.0, the solvent is water, sterilized and cooled at 115℃ for 30min and used after high temperature sterilization.
(3)发酵培养:将步骤(2)种子液以体积浓度10%的接种量接种至1L发酵培养基,在20℃,220rpm下培养12天,每天取样检测发酵液中生物量(干重)和棘白菌素B浓度;所述发酵培养基终浓度组成如下:甘油10g/L,蛋白胨8.6g/L,L-脯氨酸5g/L,甘露醇97g/L,黄豆饼粉40g/L,鸟氨酸5g/L,花生油20g/L,K2HPO4·3H2O 8.4g/L,溶剂为蒸馏水,pH值自然。(3) Fermentation culture: inoculate the seed liquid in step (2) with an inoculation amount of 10% by volume to 1 L fermentation medium, cultivate at 20° C. and 220 rpm for 12 days, and sample and detect the biomass (dry weight) in the fermentation liquid every day. and echinocandin B concentration; the final concentration of the fermentation medium is composed as follows: glycerol 10g/L, peptone 8.6g/L, L-proline 5g/L, mannitol 97g/L, soybean meal powder 40g/L , ornithine 5g/L, peanut oil 20g/L, K 2 HPO 4 ·3H 2 O 8.4g/L, the solvent is distilled water, and the pH value is natural.
发酵液中ECB含量检测采用HPLC法。样品预处理:取5ml发酵液置于10ml离心管中,5000rpm离心5min,弃沉淀、收集上清液;上清液与无水乙醇按体积比1:4混合,10000rpm离心10min,收集上清液采用0.45μm微滤膜过滤,滤液采用岛津HPLC分析。HPLC流动相配制:准确称取0.30g KH2PO3、0.35g Na2HPO3,用超纯水溶解并定容至500ml,0.45μm微滤膜过滤;滤液与色谱纯乙腈按体积比3:7混合,并采用超声波脱除气体。HPLC分析条件:岛津LC-20AT泵,岛津SPD-20A紫外-可见光检测器,色谱柱为C18柱(大连依利特4.6mm×250mm),流动相比例采用乙腈:甲醇:水=2:7:1,流速为1.0ml/min,紫外检测波长为222nm,进样量为20μL,柱温40℃。The content of ECB in the fermentation broth was detected by HPLC. Sample pretreatment: take 5ml of fermentation broth and place it in a 10ml centrifuge tube, centrifuge at 5000rpm for 5min, discard the precipitate and collect the supernatant; mix the supernatant with absolute ethanol in a volume ratio of 1:4, centrifuge at 10000rpm for 10min, and collect the supernatant It was filtered through a 0.45 μm microfiltration membrane, and the filtrate was analyzed by Shimadzu HPLC. HPLC mobile phase preparation: accurately weigh 0.30g KH 2 PO 3 and 0.35g Na 2 HPO 3 , dissolve in ultrapure water and dilute to 500ml, filter with 0.45μm microfiltration membrane; the filtrate and chromatographically pure acetonitrile are in a volume ratio of 3: 7 Mix and use ultrasonic to remove gas. HPLC analysis conditions: Shimadzu LC-20AT pump, Shimadzu SPD-20A UV-Vis detector, chromatographic column is C18 column (Dalian Elite 4.6mm × 250mm), and the mobile phase ratio is acetonitrile: methanol: water = 2:7 : 1, the flow rate is 1.0ml/min, the UV detection wavelength is 222nm, the injection volume is 20μL, and the column temperature is 40℃.
当发酵温度采用20℃,发酵过程中的最大生物量(干重)为56.8g/L,ECB的最大浓度为0.92g/L;当发酵温度为25℃,发酵过程中的最大生物量(干重)为63.7g/L,ECB的最大浓度为1.43g/L;当发酵温度采用30℃,发酵过程中的最大生物量(干重)为72.8g/L,ECB的最大浓度为1.22g/L;当发酵温度采用35℃,发酵过程中的最大生物量(干重)为67.6g/L,ECB的最大浓度为0.98g/L。试验结果见图1和图2。When the fermentation temperature was 20°C, the maximum biomass (dry weight) during the fermentation process was 56.8 g/L, and the maximum concentration of ECB was 0.92 g/L; when the fermentation temperature was 25°C, the maximum biomass (dry weight) during the fermentation process was 0.92 g/L. When the fermentation temperature is 30°C, the maximum biomass (dry weight) during the fermentation process is 72.8g/L, and the maximum concentration of ECB is 1.22g/L. L; When the fermentation temperature was 35°C, the maximum biomass (dry weight) during the fermentation process was 67.6 g/L, and the maximum concentration of ECB was 0.98 g/L. The test results are shown in Figures 1 and 2.
次级代谢产物的发酵一般分为菌体生长期和产物合成期,2个过程的最适发酵温度不同,从试验结果可以看出,当培养温度为30℃时,发酵初期菌体生长最快,获得最大干重,说明菌体的最适生长温度为30℃。当培养温度为25℃时,最终的ECB产量最大,说明ECB的最适合成温度为25℃。Fermentation of secondary metabolites is generally divided into bacterial growth phase and product synthesis phase. The optimum fermentation temperature for the two processes is different. It can be seen from the test results that when the culture temperature is 30 °C, the bacterial growth is the fastest in the early stage of fermentation. , the maximum dry weight was obtained, indicating that the optimum growth temperature of the bacteria was 30 °C. When the culture temperature was 25°C, the final ECB yield was the largest, indicating that the optimum temperature for ECB formation was 25°C.
实施例2发酵采用温度两阶段时对ECB合成所产生的影响The influence that
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养分两个阶段进行,第一阶段培养温度为30℃,第二阶段的培养温度为25℃,在发酵的第3天,从第一阶段转为第二阶段,采用实施例1的方法检测发酵液中产物ECB的浓度。The slant and seed culture are the same as in Example 1, and the fermentation culture in step (3) of Example 1 is carried out in two stages. , from the first stage to the second stage, using the method of Example 1 to detect the concentration of product ECB in the fermentation broth.
在液体深层发酵的第3天从第一阶段转为第二阶段,产物ECB的浓度为1.44g/L,试验结果见图3。On the third day of the liquid submerged fermentation, the first stage was changed to the second stage, and the concentration of the product ECB was 1.44 g/L. The test results are shown in Figure 3.
实施例3发酵采用温度两阶段时对ECB合成所产生的影响Example 3 Effect on ECB synthesis when fermentation adopts two stages of temperature
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养分两个阶段进行,第一阶段培养温度为30℃,第二阶段的培养温度为25℃,在发酵的第9天,从第一阶段转为第二阶段,采用实施例1的方法检测发酵液中产物ECB的浓度。The slant and seed culture are the same as in Example 1, and the fermentation culture in step (3) of Example 1 is carried out in two stages. The culture temperature of the first stage is 30 ° C, and the cultivation temperature of the second stage is 25 ° C. On the 9th day of fermentation , from the first stage to the second stage, using the method of Example 1 to detect the concentration of product ECB in the fermentation broth.
在液体深层发酵的第9天,从第一阶段转为第二阶段,产物ECB的浓度为0.98g/L;试验结果见图4。On the 9th day of the liquid submerged fermentation, the first stage was transferred to the second stage, and the concentration of the product ECB was 0.98g/L; the test results are shown in Figure 4.
实施例4发酵采用温度两阶段时对ECB合成所产生的影响Example 4 Effect on ECB synthesis when fermentation adopts two stages of temperature
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养分两个阶段进行,第一阶段培养温度为30℃,第二阶段的培养温度为25℃,在发酵的第6天,从第一阶段转为第二阶段,采用实施例1的方法检测发酵液中产物ECB的浓度。The slant and seed cultivation are the same as in Example 1, and the fermentation culture in step (3) of Example 1 is carried out in two stages. The cultivation temperature of the first stage is 30° C., and the cultivation temperature of the second stage is 25° C. On the sixth day of fermentation , from the first stage to the second stage, using the method of Example 1 to detect the concentration of product ECB in the fermentation broth.
在液体深层发酵的第6天,从第一阶段转为第二阶段,产物ECB的浓度为1.72g/L;试验结果见图5。On the 6th day of the liquid submerged fermentation, the concentration of the product ECB was 1.72 g/L from the first stage to the second stage; the test results are shown in Figure 5.
从试验结果可以看出,当温度转换时间点为第6天时,ECB产量最高,说明:采用温度两阶段的策略控制发酵,能有效提高ECB产量且ECB发酵的最适温度转换时间点为第6天。It can be seen from the test results that the ECB yield is the highest when the temperature transition time point is the 6th day. sky.
实施例5采用温度两阶段加上补料甘露醇时对ECB合成所产生的影响The influence that embodiment 5 produces on ECB synthesis when adopting temperature two-stage adding feeding mannitol
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为85g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,每升发酵液补加15g甘露醇,其它的培养条件完全相同,ECB的浓度为1.75g/L,试验结果见图6。Slope and seed culture are with embodiment 1, with embodiment 1 step (3) fermentation culture (mannitol content is 85g/L mannitol in fermentation medium), adopts temperature two-stage control and feeding collaboration when carrying out liquid submerged fermentation Strategic fermentation, 30°C fermentation was used for the first 6 days, and the fermentation temperature was changed to 25°C on the 7th day. During the fermentation process, mannitol was added, and 15g mannitol was added per liter of fermentation broth. The other culture conditions were exactly the same. The concentration of ECB It is 1.75g/L, and the test results are shown in Figure 6.
实施例6采用温度两阶段加上补料甘露醇时对ECB合成所产生的影响The influence that
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为70g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,每升发酵液补加30g甘露醇,其它的培养条件完全相同,ECB的浓度为1.81g/L,试验结果见图6。Slope and seed culture are the same as in Example 1, with the fermentation culture of Example 1 step (3) (the mannitol content in the fermentation medium is 70g/L mannitol), and the temperature two-stage control and feeding collaboration are adopted when carrying out liquid submerged fermentation Strategic fermentation, 30°C fermentation was used for the first 6 days, and the fermentation temperature was changed to 25°C on the 7th day. During the fermentation process, mannitol was added, and 30g mannitol was added per liter of fermentation broth. The other culture conditions were exactly the same, and the concentration of ECB It is 1.81g/L, and the test results are shown in Figure 6.
实施例7采用温度两阶段加上补料甘露醇时对ECB合成所产生的影响The influence that embodiment 7 produces on ECB synthesis when adopting temperature two-stage adding feeding mannitol
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为40g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,每升发酵液补加60g甘露醇,其它的培养条件完全相同,ECB的浓度为1.85g/L,试验结果见图6。Slope and seed culture are with embodiment 1, with embodiment 1 step (3) fermentation culture (mannitol content is 40g/L mannitol in fermentation medium), adopt temperature two-stage control and feeding collaboration when carrying out liquid submerged fermentation Strategic fermentation, 30 °C fermentation was used for the first 6 days, and the fermentation temperature was changed to 25 °C on the 7th day. During the fermentation process, mannitol was added, and 60 g of mannitol was added per liter of fermentation broth. Other culture conditions were exactly the same. The concentration of ECB It is 1.85g/L, and the test results are shown in Figure 6.
实施例8采用温度两阶段加上补料甘露醇时对ECB合成所产生的影响Example 8 The effect on ECB synthesis when two stages of temperature are added with feeding mannitol
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为55g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,每升发酵液补加45g甘露醇,其它的培养条件完全相同,ECB的浓度为1.87g/L,试验结果见图6。Slope and seed culture are with embodiment 1, with embodiment 1 step (3) fermentation culture (mannitol content is 55g/L mannitol in fermentation medium), adopt temperature two-stage control and feeding collaboration when carrying out liquid submerged fermentation Strategic fermentation, 30 °C fermentation was used for the first 6 days, and the fermentation temperature was changed to 25 °C on the 7th day. During the fermentation process, mannitol was added, and 45g mannitol was added per liter of fermentation broth. Other culture conditions were exactly the same, and the concentration of ECB It is 1.87g/L, and the test results are shown in Figure 6.
从试验结果可以看出,当补料浓度为45g/L和60g/L时,ECB产量较高,考虑到经济因素,45g/L为最优补料浓度,说明:采用温度两阶段和补料协作策略控制发酵,ECB产量提高了30.7%且ECB发酵的最适补料浓度为45g/L。It can be seen from the test results that when the feeding concentration is 45g/L and 60g/L, the output of ECB is higher. Considering economic factors, 45g/L is the optimal feeding concentration. The collaborative strategy controlled the fermentation, the ECB yield was increased by 30.7% and the optimal feed concentration for ECB fermentation was 45 g/L.
实施例9温度两阶段发酵生产ECB时不同的补加甘露醇方式对ECB合成所产生的影响Example 9 Effects of different ways of supplementing mannitol on the synthesis of ECB when producing ECB by temperature two-stage fermentation
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为55g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,在发酵第3天每升发酵液补加45g甘露醇,其它的培养条件完全相同,ECB的浓度为1.68g/L,试验结果见图7。Slope and seed culture are with embodiment 1, with embodiment 1 step (3) fermentation culture (mannitol content is 55g/L mannitol in fermentation medium), adopt temperature two-stage control and feeding collaboration when carrying out liquid submerged fermentation Strategic fermentation, 30°C fermentation was used for the first 6 days, the fermentation temperature was changed to 25°C on the 7th day, mannitol was added during the fermentation process, and 45g mannitol was added per liter of fermentation broth on the third day of fermentation, and other culture conditions were complete Similarly, the concentration of ECB was 1.68 g/L, and the test results are shown in Figure 7.
实施例10温度两阶段发酵生产ECB时不同的补加甘露醇方式对ECB合成所产生的影响Example 10 Effects of different ways of supplementing mannitol on the synthesis of ECB when producing ECB by temperature two-stage fermentation
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为55g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,在发酵第6天每升发酵液补加45g甘露醇,其它的培养条件完全相同,ECB的浓度为1.87g/L,试验结果见图8。Slope and seed culture are with embodiment 1, with embodiment 1 step (3) fermentation culture (mannitol content is 55g/L mannitol in fermentation medium), adopt temperature two-stage control and feeding collaboration when carrying out liquid submerged fermentation Strategic fermentation, 30 °C fermentation was used for the first 6 days, the fermentation temperature was changed to 25 °C on the 7th day, mannitol was added during the fermentation process, and 45g mannitol was added per liter of fermentation broth on the sixth day of fermentation, and other culture conditions were complete Similarly, the concentration of ECB is 1.87g/L, and the test results are shown in Figure 8.
实施例11温度两阶段发酵生产ECB时不同的补加甘露醇方式对ECB合成所产生的影响Example 11 Effects of different ways of supplementing mannitol on the synthesis of ECB when producing ECB by temperature two-stage fermentation
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为55g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,在发酵第9天每升发酵液补加45g甘露醇,其它的培养条件完全相同,ECB的浓度为0.9g/L,试验结果见图9。Slope and seed culture are with embodiment 1, with embodiment 1 step (3) fermentation culture (mannitol content is 55g/L mannitol in fermentation medium), adopt temperature two-stage control and feeding collaboration when carrying out liquid submerged fermentation Strategic fermentation, 30°C fermentation was used for the first 6 days, the fermentation temperature was changed to 25°C on the 7th day, mannitol was added during the fermentation process, and 45g mannitol was added per liter of fermentation broth on the 9th day of fermentation, and other culture conditions were complete Similarly, the concentration of ECB was 0.9 g/L, and the test results are shown in Figure 9.
实施例12温度两阶段发酵生产ECB时不同的补加甘露醇方式对ECB合成所产生的影响Example 12 Effects of different ways of supplementing mannitol on the synthesis of ECB when producing ECB by two-stage fermentation at temperature
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养(发酵培养基中甘露醇含量为55g/L甘露醇),在进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵,第7天发酵温度转换到25℃,在发酵过程中补加甘露醇,在发酵第3、6、9天分别在每升发酵液补加15g甘露醇,其它的培养条件完全相同,ECB的浓度为2.05g/L,试验结果见图10。Slope and seed culture are with embodiment 1, with embodiment 1 step (3) fermentation culture (mannitol content is 55g/L mannitol in fermentation medium), adopt temperature two-stage control and feeding collaboration when carrying out liquid submerged fermentation For strategic fermentation, 30°C was used for the first 6 days, the fermentation temperature was changed to 25°C on the 7th day, mannitol was added during the fermentation process, and 15g mannitol was added per liter of fermentation broth on the 3rd, 6th, and 9th days of fermentation. , the other culture conditions are exactly the same, the concentration of ECB is 2.05g/L, and the test results are shown in Figure 10.
从表1可以看出,当补料次数为3次,分别再3、6、9天共补加45g/L甘露醇时,ECB产量最高,为2.05g/L,说明:采用温度两阶段和补料协作策略控制发酵时,最有效有效的补料策略是分别在3、6、9天补加15g/L的甘露醇。As can be seen from Table 1, when the number of feedings was 3 times, and 45g/L of mannitol was added for 3, 6, and 9 days respectively, the ECB yield was the highest, which was 2.05g/L. When the cooperative feeding strategy was used to control the fermentation, the most effective feeding strategy was to add 15g/L mannitol at 3, 6 and 9 days, respectively.
表1不同补料浓度对ECB发酵的影响Table 1 Effects of different feed concentrations on ECB fermentation
实施例13温度两阶段控制策略与补料策略相互协同在一起后对ECB合成的影响。Example 13 Effects of two-stage temperature control strategy and feeding strategy synergistically on ECB synthesis.
斜面和种子培养同实施例1,将实施例1步骤(3)发酵培养采用2组平行试验,其中,第1组为对照组,采用原始的培养策略,于30℃下恒温培养,至发酵结束,第2组为试验组,进行液体深层发酵时采用温度两阶段控制和补料协作策略发酵,前6天采用30℃发酵(发酵培养基中甘露醇含量为55g/L甘露醇),第7天发酵温度转换到25℃,分别在3,6,9天补加15g/L甘露醇,3次共45g/L。试验结果见图11。The slant and seed culture are the same as in Example 1, and the fermentation culture in step (3) of Example 1 adopts two groups of parallel experiments, wherein the first group is the control group, and the original culture strategy is adopted, and the culture is maintained at a constant temperature of 30 ° C until the fermentation is completed. , the second group was the experimental group. During the liquid submerged fermentation, two-stage temperature control and feeding cooperation strategy were adopted for fermentation. The first 6 days were fermented at 30 °C (the mannitol content in the fermentation medium was 55 g/L mannitol). The seventh The fermentation temperature was changed to 25 °C on the 3rd day, and 15g/L mannitol was added on the 3rd, 6th, and 9th days respectively, for a total of 45g/L three times. The test results are shown in Figure 11.
从试验结果可以看出,采用温度两阶段和补料协作策略控制发酵时,显著的提高了ECB产量,约为对照组1.7倍,所以,温度两阶段和补料协作策略控制发酵,对ECB发酵有明显的促进作用,用广阔的工业化应用前景。It can be seen from the test results that when the fermentation is controlled by the temperature two-stage and feeding cooperative strategy, the production of ECB is significantly increased, which is about 1.7 times of the control group. It has obvious promoting effect and has broad industrial application prospects.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610544096.7A CN106011204B (en) | 2016-07-08 | 2016-07-08 | Method for synthesizing echinocandin B by fermentation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610544096.7A CN106011204B (en) | 2016-07-08 | 2016-07-08 | Method for synthesizing echinocandin B by fermentation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106011204A CN106011204A (en) | 2016-10-12 |
CN106011204B true CN106011204B (en) | 2020-01-14 |
Family
ID=57108696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610544096.7A Active CN106011204B (en) | 2016-07-08 | 2016-07-08 | Method for synthesizing echinocandin B by fermentation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106011204B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102952180A (en) * | 2011-08-24 | 2013-03-06 | 华北制药集团新药研究开发有限责任公司 | Preparation method for high-purity echinocandin B |
CN103205479A (en) * | 2012-01-17 | 2013-07-17 | 上海医药工业研究院 | Culture medium used for producing echinocandin B |
CN103509840A (en) * | 2013-10-12 | 2014-01-15 | 浙江工业大学 | Method for increasing yield of anidulafungin precursor compound Echinocandin B |
CN103555591A (en) * | 2013-10-12 | 2014-02-05 | 浙江工业大学 | Method and bacterial strain for fermentation preparation of Echinocandin B |
CN105734098A (en) * | 2016-03-25 | 2016-07-06 | 浙江工业大学 | Method for improving yield of echimocandins B |
-
2016
- 2016-07-08 CN CN201610544096.7A patent/CN106011204B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102952180A (en) * | 2011-08-24 | 2013-03-06 | 华北制药集团新药研究开发有限责任公司 | Preparation method for high-purity echinocandin B |
CN103205479A (en) * | 2012-01-17 | 2013-07-17 | 上海医药工业研究院 | Culture medium used for producing echinocandin B |
CN103509840A (en) * | 2013-10-12 | 2014-01-15 | 浙江工业大学 | Method for increasing yield of anidulafungin precursor compound Echinocandin B |
CN103555591A (en) * | 2013-10-12 | 2014-02-05 | 浙江工业大学 | Method and bacterial strain for fermentation preparation of Echinocandin B |
CN105734098A (en) * | 2016-03-25 | 2016-07-06 | 浙江工业大学 | Method for improving yield of echimocandins B |
Non-Patent Citations (4)
Title |
---|
Fungal morphology and metabolite production in submerged mycelial processes;Papagianni M;《Biotechnol Adv》;20040131;第22卷(第3期);第189-259页 * |
Melanin production by Aspergillus nidulans in batch and chemostat cultures;Rowley BI 等;《J Gen Microbiol》;19721031;第72卷(第3期);第553-563页 * |
棘白菌素B补料发酵及过程优化研究;王秋梁;《中国优秀硕士论文全文数据库 工程科技I辑》;20180615(第6期);第1-80页 * |
棘白菌素类抗生素生物合成研究进展;熊严 等;《精细与专用化学品》;20160621;第24卷(第6期);第28-32页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106011204A (en) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103992978B (en) | Leuconostoc pseudomesenteroides and method for co-producing dextran and mannitol by using same | |
CN103416223B (en) | Method for improving cordycepin output in cordyceps militaris fermentation broth | |
CN105779299B (en) | Paecilomyces hepiali strain for producing adenosine and mannitol substances and application thereof | |
WO2013155866A1 (en) | Liquid fermentation method for increasing yield of cordyceps polysaccharide by expansin | |
CN101880636A (en) | Multiple inhibitor tolerant strains of saccharomyces cerevisiae | |
CN111500472B (en) | A kind of flavonoid and polyphenol-rich mycelium of Cordyceps gunis and its production method | |
CN102703339B (en) | High-yield arginine deiminase bacterial strain and method for producing L-citrulline by same | |
CN107893033B (en) | Aspergillus fumigatus SQH4 and its application in the preparation of taxifolin by biotransformation | |
CN102925527A (en) | Method for mixing and fermenting flammulina velutipes and lucid ganoderma | |
CN105734098A (en) | Method for improving yield of echimocandins B | |
CN107189949B (en) | Rhizopus oryzae LJH3 and application thereof in preparation of genistein by biotransformation of sophoricoside | |
Bayrock et al. | Ethanol production in multistage continuous, single stage continuous, Lactobacillus-contaminated continuous, and batch fermentations | |
CN104087632B (en) | A kind of deep layer liquid fermentation produces the method for Phellinus igniarius (L. ex Fr.) Quel. extracellular polysaccharide | |
CN105580638A (en) | Method for promoting antrodia camphorata liquid state fermentation growth and triterpene synthesis | |
CN106011204B (en) | Method for synthesizing echinocandin B by fermentation method | |
CN103436567A (en) | Method for producing kojic acid by using molasses fermented by immobilized aspergillus oryzae | |
CN103509840B (en) | A kind of method improving anidulafungin precursor compound Echinocandin B output | |
CN112063574B (en) | A kind of method for improving the lycopene yield of B. trispora | |
CN101962665B (en) | Method for improving yield of cordycepin in Verticillium Paecilomyces GZ | |
CN103397054A (en) | Method for producing ethanol by enteromorpha fermentation | |
CN102041287B (en) | Method for producing polysaccharide by crossly culturing tremella fuciformis basidiospores by stages | |
CN102220397A (en) | Method for increasing yield of Cordycepin | |
CN112080535B (en) | Method for promoting synthesis and secretion of prodigiosin by using sodium humate | |
CN101575623B (en) | Method for coproducing arachidonic acid and chitosan through microbial fermentation | |
CN104862238A (en) | Saccaromyces cerevisiae and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |